Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick R Leslie

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Clinical Investigation|October 3, 2008
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viabilityAna Silva, J Andrés Yunes, Bruno A Cardoso, et al.
The Journal of Cell Biology|July 14, 2004
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteinsLaura S Harrington, Greg M Findlay, Alex Gray, et al.
Autism Research : Official Journal of the International Society for Autism Research|April 3, 2018
Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephalyChi Wai Wong, Penelope Mei Yu Or, Yubing Wang, et al.
Molecular and Cellular Biology|February 13, 2013
C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophyAra Koh, Mi Nam Lee, Yong Ryoul Yang, et al.
Molecular Cell|August 27, 2013
MC1R is a potent regulator of PTEN after UV exposure in melanocytesJuxiang Cao, Lixin Wan, Elke Hacker, et al.
Molecular and Cellular Biology|August 28, 2013
Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signalingVictoria A McGuire, Alexander Gray, Claire E Monk, et al.
Cancer Research|July 17, 2004
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivoBarbara A Spruce, Lorna A Campbell, Niall McTavish, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Clinical Investigation|October 3, 2008
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viabilityAna Silva, J Andrés Yunes, Bruno A Cardoso, et al.
The Journal of Cell Biology|July 14, 2004
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteinsLaura S Harrington, Greg M Findlay, Alex Gray, et al.
Autism Research : Official Journal of the International Society for Autism Research|April 3, 2018
Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephalyChi Wai Wong, Penelope Mei Yu Or, Yubing Wang, et al.
Molecular and Cellular Biology|February 13, 2013
C1-Ten is a protein tyrosine phosphatase of insulin receptor substrate 1 (IRS-1), regulating IRS-1 stability and muscle atrophyAra Koh, Mi Nam Lee, Yong Ryoul Yang, et al.
Molecular Cell|August 27, 2013
MC1R is a potent regulator of PTEN after UV exposure in melanocytesJuxiang Cao, Lixin Wan, Elke Hacker, et al.
Molecular and Cellular Biology|August 28, 2013
Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signalingVictoria A McGuire, Alexander Gray, Claire E Monk, et al.
Cancer Research|July 17, 2004
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivoBarbara A Spruce, Lorna A Campbell, Niall McTavish, et al.
Pageof 4